Written & medically reviewed by Dr. Sanjay Anbu, MBBS· Last reviewed
Canagliflozin is an SGLT2 inhibitor that lowers sugar and protects the kidneys. It belongs to the Oral diabetes medicine (extra) group. More tablets that control blood sugar in type 2 diabetes by different routes.
Rare serious ketoacidosis with SGLT2 (unusual symptoms — seek care)
Not a prescription — no dose shown. The right dose of canagliflozin depends on age, weight, kidney/liver function and the condition, so MedDroid does not show a dose here. Always get your dose from a doctor or pharmacist and the leaflet inside the pack. General educational information only.
Frequently asked questions
What are “gliptins” and “gliflozins”?
Gliptins (DPP-4 inhibitors, like linagliptin) gently improve insulin response; gliflozins (SGLT2 inhibitors, like canagliflozin) remove sugar via the urine and help the heart/kidneys.
Which diabetes tablet suits kidney disease?
Linagliptin needs no dose change in kidney disease, and some SGLT2 inhibitors protect the kidneys — your doctor chooses based on your kidney function.
Reviewed by Dr. Sanjay Anbu, MBBS. MedDroid is an AI medical assistant and can make mistakes. It provides general health information, not a diagnosis or medical advice — always consult a qualified clinician. In an emergency, contact your local emergency number immediately.